Trial intelligence / Profile preview

Epoetin Beta for Chemotherapy-Induced Anemia

NCT00628043Phase 3Completed

Sponsor
Chugai Pharmaceutical Co., Ltd.
Start
May 2008
Primary completion
May 2009
Modality
Erythropoietins, Colony Stimulating Factors
Countries
1
01

Overview

A Phase 3 trial of epoetin beta in Chemotherapy-induced anemia (CIA), sponsored by Chugai Pharmaceutical Co., Ltd.. Started May 2008; status: completed.

02

Drugs

epoetin beta
03

Conditions

Chemotherapy-induced anemia (CIA)

Beyond the preview

Go deeper on NCT00628043.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00628043.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call